T1D Screening to Identify Risk Before Symptoms
In this video, PA Ashlyn Smith explains how screening for type 1 diabetes can identify risk before symptoms appear and help prevent serious complications like diabetic ketoacidosis. She reviews who should be screened, available testing options—including lab and at home kits—and how early detection supports education, monitoring, and timely referral for proactive care.
Key Takeaways:
- Screen for T1D in people with family members with T1D, those with autoimmune diseases that are comorbid with T1D, and people who self-refer.
- Patients can be tested with a blood draw through a commercial lab or an at-home kit with a finger stick.
- Next steps after positive screening are patient-dependent.
Speaker
Click on the photo below to learn more about the speaker.
References and Additional Resources:
Steck AK, Rewers MJ. Genetics of type 1 diabetes. Clin Chem. 2011;57(2):176-185. https://pubmed.ncbi.nlm.nih.gov/21205883/
American Diabetes Association. Type 1 Diabetes Toolkit. Accessed February, 2026. https://professional.diabetes.org/sites/dpro/files/2024-12/121724_T1D_Toolkit.pdf
Moore DJ, Leibel NI, Polonsky W, Rodriguez H. Recommendations for screening and monitoring the stages of type 1 diabetes in the immune therapy era. Int J Gen Med. 2024;17:3003-3014. https://pmc.ncbi.nlm.nih.gov/articles/PMC11247126/
AAPA. Type 1 diabetes toolkit. Accessed February, 2026. https://www.aapa.org/education/clinical-resource-library/type-1-diabetes-toolkit/
Supported by
